noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

The Office of the Governor of the[...]

Governor Hochul Announces Syracuse Mayor Ben Walsh as Director of New[...]
The Office of the Governor of the[...]

Statement from Governor Kathy Hochul
Wisconsin Court System

Supreme Court issues order granting relief in Catholic Charities Bureau[...]

Healthcare

Malin Corporation plc

06/24/2019 | Press release | Archived content

Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies

Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab's IntelliSelect® technologies

Cambridge, UK: June 24, 2019: Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, today announced a strategic partnership agreement with LifeArc, a leading UK medical research charity. The agreement will enable LifeArc to enhance its antibody drug discovery capabilities into new medicinal products with Kymab's proprietary IntelliSelect technology platforms.

Read the full press release

Company website

Malin Corporation plc published this content on June 24, 2019, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 22, 2025 at 09:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]